Which country does avatrombopag come from?

Avatrombopag was developed by Dova Pharmaceuticals for the treatment of thrombocytopenic diseases. Avatrombopag is approved for the treatment of primary chronic immune thrombocytopenia (ITP) and the prevention of surgical bleeding in patients with low platelet levels due to chronic liver disease (CLD). Avatrombopag rapidly increases platelet levels, and this increase is maintained for a longer period of time in many patients.

Avatrombopag is sold in domestic pharmacies20mg10 tablets2700 yuan, and the domestic cost is higher. This medicine is also available in Laos and Bangladesh and has government approval. The retail price of Lucius Pharmaceutical Factory in Laos is around 600 yuan for 20 mg 28 tablets. The retail price of Laos United Pharmaceutical Factory is around 700 yuan for 20 mg of 30 tablets. The retail price of Bangladesh Ziska Pharmaceutical Factory is about 20mg 30 tablets1000yuan. The retail price of Bangladesh Yaopin International Pharmaceutical Factory is around 950 yuan for 20 mg 28 tablets. Patients can choose drug versions based on their financial situation.

Avatrombopag has not been shown to be associated with hepatotoxicity and does not require food restrictions like other oral thrombopoietin receptor agonists for immune thrombocytopeniaeltrombopag. Additionally, unlike eltrombopag for the treatment of immune thrombocytopenia, it can be administered less frequently than once daily. Avatrombopag provides another safe and effective oral option for the treatment of immune thrombocytopenia without the need for food restrictions and an alternative transfusion-sparing option for thrombocytopenia associated with chronic liver disease in patients undergoing surgery. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.